Adcock Ingram shareholders to vote on Natco Pharma acquisition bid

Adcock Ingram shareholders are called to a general meeting on Thursday, October 9, 2025, at 13:00, to vote on a scheme of arrangement. Natco Pharma South Africa Proprietary Limited proposes to acquire all Adcock Ingram shares, excluding excluded shares, for a cash consideration of ZAR75.00 per scheme share. This transaction, if implemented, will lead to the delisting of Adcock Ingram's shares from the JSE Main Board.

The circular outlining these details was published on September 9, 2025, and distributed to shareholders recorded on Friday, August 29, 2025. Key dates include Tuesday, September 30, 2025, as the last day to trade to be eligible to vote, and Friday, October 3, 2025, as the record date for the general meeting. Proxy forms must be lodged by 10:00 on Tuesday, October 7, 2025.

If the scheme is approved, the expected implementation date is Monday, November 10, 2025, with the delisting of Adcock Ingram shares expected by Tuesday, November 11, 2025. The Adcock Ingram board and independent board have collectively and individually accepted responsibility for the information in this announcement.